Heartflow
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative Heart...
Latest News
3 days ago · fool.com
HeartFlow: 3 Key Takeaways for Long-Term InvestorsFull-year 2026 revenue guidance raised to $262 million to $264 million. Plaque Analysis reduced major cardiovascular events by 34% at one year.
4 days ago · seekingalpha.com
HeartFlow, Inc. (HTFL) Q3 2026 Earnings Call TranscriptHeartFlow, Inc. (HTFL) Q3 2026 Earnings Call Transcript
4 days ago · marketbeat.com
What Heartflow (HTFL) Said on Its Q3 Earnings CallHeartflow NASDAQ: HTFL raised its 2026 revenue forecast after reporting third-quarter sales growth of 57%, citing wider adoption of its Plaque Analysis product, durable demand for FFRct and growth in coronary CT angiography.
4 days ago · zacks.com
HeartFlow (HTFL) Reports Q3 Loss, Beats Revenue EstimatesHeartFlow (HTFL) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.27 per share a year ago.
15 days ago · globenewswire.com
AHA 2026: Heartflow Plaque Analysis Associated with 34% Fewer Major CVD Events and Half the Rate of Heart Attack at One Year in Prospective DECIDE RegistryFirst plaque tool with prospective outcomes data. Faster, sustained LDL-C control: approximately 50% of patients reached goal by 90 days vs.
28 days ago · globenewswire.com
Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026SAN FRANCISCO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced it will release financial results for the third quarter of 2026 after market close on Thursday, November 12, 2026. Management will host a conference call to discuss financial results beginning at 1:30 p.m. PT / 4:30 p.m. ET on November 12, 2026.
2 months ago · fool.com
HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week HighThe transaction involved 38,900 shares valued at ~$1.8 million based on a weighted average price of $46.78 per share. The executive traded shares equal to 11% of the equity stake held before the filing.
3 months ago · globenewswire.com
Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly HalfFUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting Appropriate Use Criteria for cath lab referrals FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting Appropriate Use Criteria for cath lab referrals
3 months ago · globenewswire.com
Heartflow to Participate in the Wells Fargo 21st Annual Healthcare ConferenceSAN FRANCISCO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Wells Fargo 21st Annual Healthcare Conference. The fireside chat, which will include a slideshow presentation followed by a question-and-answer session, will take place in Boston on Wednesday, September 9, 2026, at 3:45 p.m. ET / 12:45 p.m. PT.
3 months ago · fool.com
HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors?The executive sold 9,219 shares at $41.23 per share on August 17, 2026, generating ~$380,100. The transaction reduced the insider's direct equity position by 10%, while total beneficial ownership decreased by 4%.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove HTFL